Showing 101 - 120 results of 2,670 for search '"radiosensitivity"', query time: 0.12s Refine Results
  1. 101
  2. 102
  3. 103

    Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition by Rasmussen Heidi, Bratland Åse, Folkvord Sigurd, Nome Ragnhild V, Flatmark Kjersti, Ellefsen Mali, Fodstad Øystein, Ree Anne

    Published 2006-08-01
    “…<p>Abstract</p> <p>Background</p> <p>The tumor response to preoperative radiotherapy of locally advanced rectal cancer varies greatly, warranting the use of experimental models to assay the efficacy of molecular targeting agents in rectal cancer radiosensitization. Histone deacetylase (HDAC) inhibitors, agents that cause hyperacetylation of histone proteins and thereby remodeling of chromatin structure, may override cell cycle checkpoint responses to DNA damage and amplify radiation-induced tumor cell death.…”
    Get full text
    Article
  4. 104
  5. 105
  6. 106
  7. 107
  8. 108
  9. 109

    Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy by Xiang-Yu Su, Pei-Dang Liu, Hao Wu, Ning Gu

    Published 2014-06-01
    “…However, resistance of tumor cells to radiation therapy still remains a serious concern, so the study of radiosensitizers has emerged as a persistent hotspot in radiation oncology. …”
    Get full text
    Article
  10. 110

    Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity by Sophie Deneuve, Céline Mirjolet, Thierry Bastogne, Mirlande Duclos, Paul Retif, Philippe Zrounba, Pierre-Eric Roux, Marc Poupart, Guillaume Vogin, Nicolas Foray, Sandrine Pereira

    Published 2021-05-01
    “…Recent studies stressed the role of the phosphorylated ATM (pATM) protein in RT-toxicity genesis and its ability in predicting individual radiosensitivity (IRS) in fibroblasts. Here we assessed the reliability of the pATM quantification in lymphocytes to predict IRS. …”
    Get full text
    Article
  11. 111

    Repurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer by Lisa Kerkhove, Febe Geirnaert, Amir Laraki Rifi, Ka Lun Law, Adrián Gutiérrez, Inge Oudaert, Cyril Corbet, Thierry Gevaert, Inès Dufait, Mark De Ridder

    Published 2023-04-01
    “…Our principal finding in human HCT116 and DLD-1 cells was that SSZ enhances the radiosensitivity of hypoxic CRC cells but does not alter the intrinsic radiosensitivity. …”
    Get full text
    Article
  12. 112

    Active caspase-3 expression levels as bioindicator of individual radiosensitivity by NEYLIANE F.G. DOS SANTOS, RAFAEL F. SILVA, MARCELA M.P.L. PINTO, EDVANE B. DA SILVA, DEBORAH R. TASAT, ADEMIR AMARAL

    “…For each radiation dose, it was observed a significant inter-individual variation in active caspase-3 expression intensity, suggesting that this parameter may be suitable for evidence individual radiosensitivity. The methodology presented and discussed in this work may help to predict healthy tissues response to radiation exposure toward the better patient outcome.…”
    Get full text
    Article
  13. 113

    Radiosensitivity of Cancer Cells Is Regulated by Translationally Controlled Tumor Protein by Jiwon Jung, Ji-Sun Lee, Yun-Sil Lee, Kyunglim Lee

    Published 2019-03-01
    “…This study reveals that the regulation of radiosensitivity of cancer cells is yet another function of TCTP. …”
    Get full text
    Article
  14. 114

    Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma by Jessica Buck, Jessica Buck, Patrick J. C. Dyer, Hilary Hii, Brooke Carline, Mani Kuchibhotla, Jacob Byrne, Meegan Howlett, Meegan Howlett, Jacqueline Whitehouse, Jacqueline Whitehouse, Martin A. Ebert, Martin A. Ebert, Kerrie L. McDonald, Nicholas G. Gottardo, Nicholas G. Gottardo, Raelene Endersby, Raelene Endersby

    Published 2021-04-01
    “…In summary, PARP inhibition enhanced radiation-induced cytotoxicity of medulloblastoma cells; thus, veliparib or other brain-penetrant PARP inhibitors are potential radiosensitizing agents for the treatment of medulloblastoma.…”
    Get full text
    Article
  15. 115

    Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy by Omer Gal, Oshra Betzer, Liat Rousso-Noori, Tamar Sadan, Menachem Motiei, Maxim Nikitin, Dinorah Friedmann-Morvinski, Rachela Popovtzer, Aron Popovtzer

    Published 2022-09-01
    “…The inability of drugs to enter the brain, in particular antibody-based drugs and radiosensitizers, is a crucial limitation to effective glioblastoma therapy. …”
    Get full text
    Article
  16. 116
  17. 117
  18. 118
  19. 119

    Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. by Daniel Y Joh, Lova Sun, Melissa Stangl, Ajlan Al Zaki, Surya Murty, Phillip P Santoiemma, James J Davis, Brian C Baumann, Michelle Alonso-Basanta, Dongha Bhang, Gary D Kao, Andrew Tsourkas, Jay F Dorsey

    Published 2013-01-01
    “…Prior treatment of mice with brain tumors resulted in increased extravasation and in-tumor deposition of GNP, suggesting that RT-induced BBB disruption can be leveraged to improve the tumor-tissue targeting of GNP and thus further optimize the radiosensitization of brain tumors by GNP. These exciting results together suggest that GNP may be usefully integrated into the RT treatment of brain tumors, with potential benefits resulting from increased tumor cell radiosensitization to preferential targeting of tumor-associated vasculature.…”
    Get full text
    Article
  20. 120